CN211434774U

CN211434774U - Light radiation beta amyloid dermatitis treatment instrument, treatment blanket and treatment coat

Info

Publication number: CN211434774U
Application number: CN201920947151.6U
Authority: CN
Inventors: 莫国良; 莫非
Original assignee: Individual
Current assignee: Individual
Priority date: 2019-06-21
Filing date: 2019-06-21
Publication date: 2020-09-08
Anticipated expiration: 2029-06-21

Abstract

The utility model discloses an optical radiation beta amyloid dermatitis therapeutic equipment, including therapeutic lamp area, therapeutic lamp area includes the supporting body and arranges LED lamp pearl on the supporting body, wherein, LED lamp pearl sends wavelength 550 +/-50 nm's visible light and is in arrange more than 1 with every square centimeter on the supporting body. The utility model provides an optical radiation beta amyloid dermatitis therapeutic apparatus converts the electric energy into the controlled light energy that is used for the specific wavelength of treatment purpose through illuminator, utilizes it and human tissue to take place thermal action, photochemistry effect and/or biostimulation effect, reaches the purpose of treatment, adjunctie therapy or alleviating. The utility model provides a light radiation beta amyloid dermatitis therapeutic equipment can improve treatment to starch dermatitis or radical cure. The utility model also provides a therapeutic blanket and a therapeutic jacket which adopt the optical radiation beta amyloid dermatitis therapeutic apparatus.

Description

Light radiation beta amyloid dermatitis treatment instrument, treatment blanket and treatment coat

Technical Field

The utility model relates to the technical field of medical equipment, concretely relates to optical radiation beta amyloid dermatitis treatment apparatus, treatment blanket and treatment jacket.

Background

Amyloidosis refers to a disease caused by the deposition of amyloid in a tissue or organ, and is practically independent of starch. The disease is generally considered to be autosomal dominant inheritance or to be associated with metabolic disorders. The two types are classified as systemic or cutaneous amyloidosis, with primary and secondary differentiation due to the different organs involved.

Depending on the lesion, cutaneous amyloidosis is classified: licheniform amyloidosis, plaque amyloidosis, mixed amyloidosis, nodular amyloidosis, and cutaneous heterochromosis amyloidosis.

Licheniform amyloidosis is most common, with an unlimited age of onset. Typical skin lesions are papules which occur in front of the calf shank and have normal skin color to yellow brown, the size is about I-3 mm, the surface is often provided with a few scales, and the top end is often hyperkeratotic and coarse; the papules are densely formed into pieces, but are not always fused, and are itchy in a conscious way. Sometimes the pimples are arranged in a moniliform and characteristic along the skin veins. Can also be fused into plaques, the surface of the plaques is warty, similar to hypertrophic lichen planus or lichen simplex chronicus, papules on the surface of the plaques can be identified, and brown papules can also be seen on the edges of the plaques. Over time, the skin lesions gradually spread to the flexed side of the lower leg, the thigh, the ankle and the instep, and occasionally to the extended side of the forearm, the abdomen or the chest wall.

The porphyritic amyloidosis is less common than the licheniform amyloidosis, and is characterized in that spot pigment spots are gathered into corrugated or reticular brown pigment spots which are symmetrically distributed in the shoulder blade area, the crus, the arms, the breasts and the buttocks of the back, moderate pruritus is caused, and the postinflammatory pigmentation is easy to misdiagnose.

Sometimes both licheniform and plaque lesions may be present and may transform into each other, called biphasic or mixed cutaneous amyloidosis. The disease is chronic, often persists for years, can resolve by itself, but can recur.

Very few patients exhibit nodular amyloidosis, as well as cutaneous heterochromopathic amyloidosis. The skin damage of the former is represented by a plurality of brown soybeans to peanuts with different numbers, and the soybeans are higher than the skin surface of the peanuts, are hard and faithful, and are sometimes accompanied by severe pruritus; the latter resembles the amyloid plaques, but is pathologically characterized by hyperpigmentation, hypopigmentation, telangiectasia, epidermal atrophy, and the like.

Currently, the commonly used treatment methods are:

1) the western medicine treatment mainly adopts external application of vitamin A acid drugs, corticosteroid hormone and other ointments to smear;

2) the traditional Chinese medicine adopts heat-clearing and detoxifying oral administration;

3) the physical therapy adopts laser ablation;

however, the effects of the three treatment methods are not obvious, and the treatment cannot be radically cured at present.

The applicant himself is also the patient of this disease species. The initial onset was in 2008, when the lesions originated in a small pustule on the back and itching occurred in the lesions on the back. Because of the carelessness of the user, the user can scratch the itching with hands and does not feel the itching for a long time, the small pustules spread, the back is infected in a large area and then the back is infected to the outer side of the second arm, large-area fester is formed, and finally amyloid scleroma nodules are formed.

Thereafter, the applicant saw a diagnosis in 2010 in a certain three hospitals in Shanghai and was confirmed to be "β amyloid dermatosis" by sectioning. After that, treatment was continued in the hospital, but no results were obtained. Then, the patient goes to several hospitals in other Shanghai markets for treatment. The prescription is almost consistent with the prescription in the hospital, and the effect is not obvious. In this way, the applicant goes to a certain Shanghai TCM hospital to see a doctor. The traditional Chinese medicine has the means of clearing away heat and toxic materials, and the disease condition is not relieved after the decoction is taken for a while.

The applicant provides a therapeutic device for treating beta amyloid dermatitis through light radiation by combining the working experience of researching and developing medical devices for many years and the research on beta amyloid skin diseases and visible light treatment skin diseases, so as to improve the treatment effect or radically cure the beta amyloid dermatitis.

SUMMERY OF THE UTILITY MODEL

An object of the utility model is to provide an optical radiation beta amyloid dermatitis therapeutic equipment to improve treatment or radically cure. Another object of the present invention is to provide a therapeutic blanket and a therapeutic jacket using the above mentioned therapeutic apparatus for light radiation amyloid beta dermatitis.

In order to achieve the above object, the utility model adopts the following technical scheme:

the utility model provides a light radiation beta amyloid dermatitis therapeutic equipment, includes treatment lamp area, treatment lamp area includes the supporting body and arranges LED lamp pearl on the supporting body, LED lamp pearl sends the visible light of wavelength 550 ± 50nm and arranges more than 1 per square centimeter on the supporting body.

Preferably, the LED lamp beads are patch type lamp beads emitting scattered light, and the lamp beads are connected in series.

Preferably, each LED lamp bead is a lamp bead with power of 0.06W and direct current of 12V, and an adapter with power of direct current of 12V and 6W is adopted for supplying power.

Preferably, the LED lamp comprises a control device, a temperature sensor and a power switch, wherein the control device, the temperature sensor and the power switch are arranged on the supporting body, and the control device controls the LED lamp beads according to a temperature signal provided by the temperature sensor.

A therapeutic blanket comprises a blanket body and further comprises a light radiation beta amyloid dermatitis therapeutic apparatus, wherein the therapeutic lamp strip is arranged on the blanket body.

Preferably, the therapeutic lamp strips are arranged on the blanket body in multiple rows, and the multiple rows of therapeutic lamp strips are connected in series or in parallel.

A therapeutic coat comprises a coat body and further comprises the optical radiation beta amyloid dermatitis therapeutic equipment, wherein the therapeutic lamp strip is arranged on the coat body.

Preferably, the therapeutic lamp belts are arranged in a plurality of rows in series or in parallel at the back part of the inner side of the coat body.

Preferably, in the above aspect, the therapeutic light band extends from a left cuff on an inner side of the jacket body to a right cuff on the inner side of the jacket body.

Due to the structure, the beneficial effects of the utility model reside in that:

1. the optical radiation beta amyloid dermatitis therapeutic apparatus provided by the application converts electric energy into controlled light energy with specific wavelength for therapeutic purpose through the light-emitting device, and achieves the purpose of treatment, auxiliary treatment or alleviation by utilizing the thermal effect, photochemical effect and/or biological stimulation effect of the optical radiation beta amyloid dermatitis therapeutic apparatus and human tissues;

2. the application provides a treatment blanket and treatment jacket only needs before the sleep evening, and it is fixed to hug closely the affected part with the lamp pearl of lamp blanket, or wear the light shirt, plugs in the switch on adapter, treats 10 minutes after, according to the adaptation condition of skin to the temperature, the temperature regulation to after most comfortable can, simple and convenient need not to take or paint the medicine.

Drawings

In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings used in the description of the embodiments will be briefly described below.

Fig. 1 is a schematic structural view of the therapeutic blanket of the present invention;

fig. 2 is a schematic structural view of the therapeutic jacket of the present invention.

Detailed Description

The technical solution of the present invention will be clearly and completely described below with reference to the accompanying drawings of the present invention. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative efforts belong to the protection scope of the present invention.

Referring to fig. 1 and 2, the light radiation β amyloid dermatitis therapeutic apparatus provided in this embodiment includes a therapeutic lamp strip 2, the therapeutic lamp strip 2 includes a supporting body and LED lamp beads 1 arranged on the supporting body, the LED lamp beads 1 emit visible light with a wavelength of 550 ± 50nm and are arranged on the supporting body at a rate of 1 per square centimeter.

The LED lamp beads 1 are patch type lamp beads emitting scattered light, and the lamp beads are connected in series. Each LED lamp bead 1 is a lamp bead with power of 0.06W and direct current of 12V, and an adapter with power of direct current of 12V and 6W is adopted for supplying power.

The light radiation beta amyloid dermatitis treatment instrument that this embodiment provided still includes controlling means, temperature sensor and the switch of power supply of setting on the supporting body, and controlling means controls LED lamp pearl according to the temperature signal that temperature sensor provided, and in this embodiment, controlling means, temperature sensor and switch all adopt prior art, and controlling means can adopt the model to be LPC 1114's microprocessor, and temperature sensor can adopt model DS18B 20.

The embodiment also provides a therapeutic blanket, which comprises a blanket body 3, wherein the optical radiation beta amyloid dermatitis therapeutic apparatus is mounted on the blanket body, and the therapeutic lamp strip 2 is arranged on the blanket body 3.

Specifically, the therapeutic lamp strip 2 is arranged on the blanket body 3 in a plurality of rows. The multiple rows of therapeutic lamp belts 2 are connected in series or in parallel.

The embodiment also provides a therapeutic coat, which comprises a coat body 4, wherein the optical radiation amyloid beta dermatitis therapeutic apparatus is mounted on the coat body 4, and the therapeutic lamp strip 2 is arranged on the coat body 4.

Specifically, the therapeutic lamp bands 2 are arranged in a plurality of rows in series or in parallel at the back part of the inner side of the coat body 4. The therapeutic lamp strip 2 extends from the left sleeve opening on the inner side of the jacket body 4 to the right sleeve opening on the inner side of the jacket body 4.

The treatment blanket and the treatment coat provided by the embodiment both provide a carrier for the optical radiation beta amyloid dermatitis treatment instrument, and are more convenient for a patient to use.

Particularly, the therapeutic light blanket and the therapeutic jacket mainly ensure the close fitting of light, so that the effective radiation of light can not damage the skin, and low-temperature and high-temperature burns can be avoided.

Wherein the content of the first and second substances,

the using method of the therapeutic blanket comprises the following steps:

before sleeping at night, the lamp bead of the therapeutic blanket is tightly attached to the affected part and fixed, a power switch is plugged in, a power switch is turned on, and after 10 minutes, the temperature is adjusted to be the most comfortable according to the adaptive temperature of the skin to the temperature.

The application method of the therapeutic coat comprises the following steps:

the treatment coat is put on before sleeping at night, the power supply is plugged in to connect the adapter, the power supply switch is turned on, and after 10 minutes, the temperature is adjusted to be the most comfortable according to the adaptive temperature of the skin to the temperature.

The amyloid fatty acid is irradiated by 550 +/-50 nm visible light with certain illumination intensity for a long time, so that the amyloid fatty acid is dissolved in sweat glands of a human body and is discharged out of the human body, the treatment effect is achieved, and the amyloid fatty acid injection is convenient to use and can be used for a long time.

The optical radiation beta amyloid dermatitis therapeutic apparatus provided by the embodiment converts electric energy into controlled light energy with specific wavelength for therapeutic purpose through the light-emitting device, and achieves the therapeutic or auxiliary therapeutic purpose by utilizing the thermal effect, photochemical effect and/or biological stimulation effect of the optical radiation beta amyloid dermatitis therapeutic apparatus and human tissues. The light radiation is used for interfering the amyloid fatty acid of the patient, dissolving in the sweat gland and discharging.

The optical radiation beta amyloid dermatitis treatment instrument provided by the embodiment has the following theoretical basis:

(1) einstein's theory of photon hypothesis

The photon hypothesis successfully explains the photoelectric effect. When light with a short wavelength, such as ultraviolet light, is irradiated on the surface of a metal, electrons are emitted from the metal, and this phenomenon is called a photoelectric effect. It is found in hertz (h.r.hertz l 857-1894) and lenard (p.lenard l 862-1947). The experiment of the photoelectric effect shows that: weak violet light can emit electrons from the metal surface, while strong red light cannot emit electrons, i.e. the photoelectric effect is generated only depending on the frequency of light and independent of the intensity of light. This phenomenon is not explained by fluctuations in light. Because light fluctuations say light is a wave whose energy is continuous, depending on the amplitude, i.e. intensity, of the light wave, but not on the frequency, i.e. color, of the light, if weak violet light can beat electrons from a metal surface, strong red light should beat electrons more, and the fact is the opposite. The photoelectric effect can be satisfactorily explained by using the optical quantum hypothesis. According to the photon hypothesis, light is composed of photons, the energy of which is discontinuous, and the energy of each photon reaches a certain value to overcome the work function of an electron and eject the electron from the metal surface. Although the number of weak violet light is small, the energy of each light quantum is large enough, so that electrons can be emitted from the metal surface; strong red light, the number of light quanta is many, but the energy of each light quantum is not large enough to overcome the escape of electrons, so that the electrons cannot be emitted.

(2) Lambert's law of light absorption

The absorption of light corresponds to the transition of electrons, for free ions or ions (such as rare earth ions) which are not strongly coupled with neighboring ions, the absorption spectrum is a line spectrum, the discrete energy level of corresponding atoms, and for ions which have strong interaction with crystal lattices, the absorption spectrum is in an inverted bell shape, and the width can reach dozens of nanometers.

This absorption spectrum is called absorption band (absorption band), and when the wavelength is short to a certain value, usually in the short-wave part of the ultraviolet region or visible region, the absorption coefficient rapidly increases by several orders of magnitude, and the wavelength (frequency) at which the absorption coefficient steeply increases is called absorption edge or absorption edge (absorption edge) corresponding to the interval between the lowest point of the conduction band and the highest point of the valence band, i.e. the forbidden bandwidth (band gap), of photon energy.

The energy state in the substance can be known through the measurement of the absorption spectrum, the absorption edge is accurately measured, and the value of the band gap can be obtained. Direct and indirect bands can also be distinguished from the shape of the absorption spectrum, since indirect inter-band transitions involve phonons and the absorption is not as strong as the direct band. The change of the absorption coefficient along with the wavelength is not as rapid, the exciton has a hydrogen-like energy level, the absorption spectrum of the exciton is close to the absorption edge, and experiments prove that theoretically, the transition probability between the 4f energy levels of the rare earth ions can be calculated through the integral area of the absorption spectrum line, so that the probability of the nonradiative transition can be estimated, and the band gap measured by an absorption method is called an optical band gap.

The emission and absorption bands may sometimes overlap partially, in which case the emission of one activator may be absorbed by another activator of the same type, called self-absorption. When the activator concentration is sufficiently high, self-absorption can be quite significant. The distortion due to self-absorption must then be taken into account for correct measurement of the luminescence spectrum.

According to the theory, the working mechanism of the visible light therapeutic medical device can be clear as follows:

mainly utilizes the photothermal action, photochemical action and/or biological stimulation action of the medicine and human tissues to achieve the purpose of treatment or adjuvant treatment.

Heat action: biological tissues absorb light energy and convert the light energy into heat energy under the irradiation of light, and the temperature is increased, namely, the heat action. The temperature rise will cause thermalization and biomolecule denaturation in the biological tissue, affecting the metabolic rate, blood circulation and nerve cells, and causing thermal damage. The threshold temperature of the biological tissue lesion is different for different irradiation times. The shorter the irradiation time, the higher the temperature that the biological tissue can withstand. As the temperature rises, the reaction of erythema, blisters, etc. will occur successively on the skin and soft tissues starting from heat-induced warming (38 ℃ to 42 ℃). Clinically, thermotropic hyperthermia and erythema are used for physical therapy.

Photochemical reaction: it means that biomolecules are activated by light to generate excited atoms, molecules and free radicals, and cause a series of chemical reactions in vivo. The action of light irradiation directly causing the body to undergo photochemical reactions is called photochemical action. Photochemical reaction can result in the denaturation and inactivation of enzyme, amino acid, protein and nucleic acid, etc., and the molecular structure may be changed in different degrees, so as to produce corresponding biological effects, such as bactericidal effect, erythema effect, pigmentation, vitamin synthesis, etc. The photochemical reaction process can be divided into photolysis, photooxidation, photopolymerization, photoisomerization, photosensitization indirect action and the like. One of the most fundamental principles of photochemical reactions is that a particular photochemical reaction is initiated by photons of a particular wavelength. Photons causing photochemical reactions have wavelengths in the near ultraviolet and visible region in the range of 350nm to 700 nm. Each tissue of the organism (including normal and abnormal tissues) has certain selective absorption of light with different wavelengths.

Biological stimulation: the weak laser is also called low-power laser and cold laser, and generally refers to laser with output laser power of milliwatt level. When a low power laser irradiates biological tissue, it cannot destroy the tissue to coagulate, vaporize, char, etc., and does not directly cause irreversible damage to the biological tissue, but rather produces a mechanical or thermal effect, known as laser biostimulation. After the biological tissue absorbs the energy of weak laser, the energy state of the biological tissue is changed, the tissue is stimulated along with weak thermal effect and photochemical effect, and the tissue regeneration and the wound healing are facilitated by improving blood circulation and promoting the dissipation and absorption of inflammation.

The curative effect is as follows:

experimental validation of visible light on amyloid bio-fatty acid mice has been published in the atlantic journal:

doctor Tsai has stimulated the mice with LED lamps that flash at a rate of 40 flashes per second, and surprisingly found that the frequency of gamma waves in the cerebral visual cortex of the mice is really increased and amyloid beta is reduced by half. However, within 24 hours, the amyloid beta levels returned to the original levels. Later the Tsai team tried to photostimulate mice for one hour each time over a 7 day period. As a result, the amyloid beta lumps in the visual cortex of the brain of the mouse are reduced, and the free amyloid beta is also obviously reduced.

The above is only a preferred embodiment of the present invention, and is not intended to limit the present invention, and various modifications and changes will occur to those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. An optical radiation beta amyloid dermatitis treatment apparatus, characterized in that: the LED lamp comprises a supporting body and LED lamp beads arranged on the supporting body, wherein the LED lamp beads emit visible light with the wavelength of 550 +/-50 nm and are arranged on the supporting body in a manner of more than 1 per square centimeter.

2. The apparatus for treating amyloid-beta dermatitis as claimed in claim 1, wherein: the LED lamp beads are patch type lamp beads emitting scattered light, and the lamp beads are connected in series.

3. The apparatus for treating amyloid-beta dermatitis as claimed in claim 1, wherein: each LED lamp bead is a lamp bead with power of 0.06W and direct current of 12V, and an adapter with power of direct current of 12V and 6W is adopted for power supply.

4. The apparatus for treating amyloid-beta dermatitis as claimed in claim 1, wherein: still including setting up controlling means, temperature sensor and switch on the supporting body, controlling means is according to the temperature signal that temperature sensor provided is right LED lamp pearl is controlled.

5. A therapeutic blanket, comprising a blanket body, characterized in that: further comprising the optical radiation amyloid beta dermatitis therapeutic device according to any one of claims 1 to 4, wherein the therapeutic light strip is disposed on the blanket body.

6. The therapeutic blanket of claim 5, wherein: the therapeutic lamp belts are arranged on the blanket body in a plurality of rows, and the therapeutic lamp belts in the plurality of rows are mutually connected in series or in parallel.

7. The utility model provides a treatment jacket, includes the jacket body, its characterized in that: the therapeutic apparatus for treating beta amyloid dermatitis as claimed in any one of claims 1 to 4, further comprising a therapeutic light strip disposed on the upper body.

8. The therapeutic coat of claim 7, wherein: the therapeutic lamp belts are arranged on the back part of the inner side of the coat body in a plurality of rows in series or in parallel.

9. The therapeutic coat of claim 7, wherein: the therapeutic lamp belt extends from the left sleeve opening on the inner side of the jacket body to the right sleeve opening on the inner side of the jacket body.